Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
出版年份 2016 全文链接
标题
Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
作者
关键词
-
出版物
Nature Communications
Volume 7, Issue -, Pages 10787
出版商
Springer Nature
发表日期
2016-02-23
DOI
10.1038/ncomms10787
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage
- (2015) Pallavi Manral et al. BIOSCIENCE REPORTS
- A unified framework based on the binding polynomial for characterizing biological systems by isothermal titration calorimetry
- (2015) Sonia Vega et al. METHODS
- Repurposing Diflunisal for Familial Amyloid Polyneuropathy
- (2015) John L. Berk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quantification of Quaternary Structure Stability in Aggregation-Prone Proteins under Physiological Conditions: The Transthyretin Case
- (2014) Lei Z. Robinson et al. BIOCHEMISTRY
- Age-Related Oxidative Modifications of Transthyretin Modulate Its Amyloidogenicity
- (2013) Lei Zhao et al. BIOCHEMISTRY
- Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy
- (2013) P. Lozeron et al. EUROPEAN JOURNAL OF NEUROLOGY
- Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial
- (2013) I. S. J. Merkies NEUROLOGY
- AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin
- (2013) S. C. Penchala et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
- (2012) Steven M. Johnson et al. JOURNAL OF MOLECULAR BIOLOGY
- Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
- (2012) C. E. Bulawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs
- (2011) Steve Bourgault et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dissecting the Structure, Thermodynamic Stability, and Aggregation Properties of the A25T Transthyretin (A25T-TTR) Variant Involved in Leptomeningeal Amyloidosis: Identifying Protein Partners That Co-Aggregate during A25T-TTR Fibrillogenesis in Cerebrospinal Fluid
- (2011) Estefania P. C. Azevedo et al. BIOCHEMISTRY
- Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
- (2011) Nelson Ferreira et al. FEBS LETTERS
- Transthyretin-related amyloidoses and the heart: a clinical overview
- (2010) Claudio Rapezzi et al. Nature Reviews Cardiology
- Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity
- (2009) Nelson Ferreira et al. FEBS LETTERS
- Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis
- (2009) Jinchun Sun et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Do enthalpy and entropy distinguish first in class from best in class?
- (2008) E FREIRE DRUG DISCOVERY TODAY
- Toward Optimization of the Linker Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies†
- (2008) Steven M. Johnson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biochemical and Structural Evaluation of Highly Selective 2-Arylbenzoxazole-Based Transthyretin Amyloidogenesis Inhibitors
- (2007) Steven M. Johnson et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started